questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the Serious Shortage Protocols in place for Creon 10,000 and 25,000 capsules limiting prescriptions to one months’ supply; and what steps he is taking to ensure children with cystic fibrosis have access to that medication.
answerText: The Department has been working with suppliers to address current supply issues with pancreatic enzyme replacement therapy (PERT), including Creon, to help ensure patients, including children with cystic fibrosis, have access to this medicine. The supply ...
heading: Pancreatic Enzyme Replacement Therapy: Shortages